Live Breaking News & Updates on Drug Repurposing|Page 15

Stay updated with breaking news from Drug repurposing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Changes in how cholesterol breaks down in the body may accelerate progression of dementia


 E-Mail
IMAGE: Investigators with the National Institute on Aging, part of the National Institutes of Health, are searching for drug candidates that may correct the brain s metabolic abnormalities, such as cholesterol breakdown.
view more 
Credit: Dr. Vijay R. Varma
The blood-brain barrier is impermeable to cholesterol, yet high blood cholesterol is associated with increased risk of Alzheimer s disease and vascular dementia. However, the underlying mechanisms mediating this relationship are poorly understood. A study published in the open-access journal
PLOS Medicine by Vijay Varma and colleagues at the National Institute on Aging, part of the National Institutes of Health, in Baltimore, Maryland, suggests that disturbances in the conversion of cholesterol to bile acids (called cholesterol catabolism) may play a role in the development of dementia. ....

National Institutes Of Health , United States , United Kingdom , Lilliana Posey , Madhav Thambisetty , Vijay Varma , National Cancer Institute , Alzheimer Disease Neuroimaging Initiative , Consortium Molecular Mechanisms Of The Vascular Etiology , National Institute On , Research Article , Medicines Partnership , Laboratory Of Behavioral Neuroscience , National Institute On Aging , National Institute , National Institutes , Baltimore Longitudinal Study , Disease Neuroimaging Initiative , Translational Neuroscience , Drug Repurposing , Effective Alzheimer , Accelerated Medicines Partnership , Target Discovery , Preclinical Validation Project , Molecular Mechanisms , Vascular Etiology ,

Repurposed gout medication (probenecid) shows potent inhibition of SARS-CoV-2 replication

New research by a team of scientists in the USA describes the potential utility of a drug called probenecid, commonly used to treat gout, to treat this devastating viral illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative virus of COVID-19. ....

United States , United Kingdom , Liji Thomas , Drug Administration , Probenecid Inhibits , Image Credit , Cagkan Sayin , Antiviral Drug , Coronavirus Disease Covid 19 , Drug Repurposing , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , படம் கடன் ,

The potential therapeutic value of CDK6 inhibitors in critical COVID-19

While drug repurposing has been explored in the context of the current coronavirus disease 2019 (COVID-19) pandemic, the success of this strategy has been limited so far. A new study, released as a preprint on the medRxiv server, describes a new method of identifying a promising hit among drugs already in use. ....

Liji Thomas , United Kingdom Biobank , Antiviral Drug , Coronavirus Disease Covid 19 , Ars Cov 2 , Acute Respiratory Distress Syndrome , Body Mass Index , C Reactive Protein , Drug Repurposing ,

New computational tool helps screen molecules for their potential COVID-fighting properties


New computational tool helps screen molecules for their potential COVID-fighting properties
A year into the COVID-19 pandemic, mass vaccinations have begun to raise the tantalizing prospect of herd immunity that eventually curtails or halts the spread of SARS-CoV-2. But what if herd immunity is never fully achieved - or if the mutating virus gives rise to hyper-virulent variants that diminish the benefits of vaccination?
Those questions underscore the need for effective treatments for people who continue to fall ill with the coronavirus. While a few existing drugs show some benefit, there s a pressing need to find new therapeutics.
Led by The University of New Mexico s Tudor Oprea, MD, PhD, scientists have created a unique tool to help drug researchers quickly identify molecules capable of disarming the virus before it invades human cells or disabling it in the early stages of the infection. ....

United States , Suman Sirimulla , Emily Henderson , Tudor Oprea , School Of Medicine , Translational Informatics Division , National Center , University Of New Mexico , University Of New Mexico Tudor Oprea , University Of Texas At El Paso , Translational Sciences , New Mexico , Nature Machine Intelligence , Advancing Translational Sciences , Corona Virus , Drug Repurposing , Machine Learning , Ars Cov 2 , ஒன்றுபட்டது மாநிலங்களில் , எமிலி ஹென்டர்சன் , பள்ளி ஆஃப் மருந்து , மொழிபெயர்ப்பு தகவல் பிரிவு , தேசிய மையம் , பல்கலைக்கழகம் ஆஃப் புதியது மெக்ஸிகோ , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் இல் எல் பாசோ , மொழிபெயர்ப்பு அறிவியல் ,

Global To Help The Drug Repurposing Market Stand In A Good Stead – KSU


atulpmrApril 24, 2021
1
The Drug Repurposing Market report by Persistence Market Research is focusing on the fact that healthcare providers are into collection of socioeconomic information of the patients, so that tracking at any point of time is possible. This on-the-go monitoring is amongst the ongoing trends in the healthcare industry.
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive ....

New York , United States , Asia Pacific , National Center , Allergan Plc , National Institute Of Health , Us Department Of Health , Translational Sciences , Persistence Market Research , Astellas Pharma Inc , Pfizer Inc , Abbvie Inc , Drug Repurposing , Latin America , Middle East , North America , Advancing Translational , Extensive Coverage , Persistence Market Research Healthcare , Market Research , New York City , States Canada Toll Free , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஆசியா பெஸிஃபிக் , தேசிய மையம் ,